INNVHealthcare · Medical Care FacilitiesThe 3 Wall Street analysts covering InnovAge Holding Corp. hold a median 12-month price target of $12 — +22.7% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 99 of 100 as at 4 Nov 2026 — among the strongest tenth. Here, the model and the Street point the same way.
Consensus tells you what everyone already believes. The model scores InnovAge Holding Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Quality (91): The business earns solid, repeatable profits on what it owns.
Volatility (60): The share price moves around a lot.
Size (40): Larger than most of the companies we track — more scrutinised, less often mispriced.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
The bullish and bearish analyst opinions on INNV, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +22.7% from it.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 9 Sept 2026 | Keybanc | Maintains | Overweight | $13 → $14 |
| 21 Aug 2026 | Keybanc | Upgrade | Overweight | — |
| 21 Aug 2026 | Keybanc | Upgrade | Overweight | $13 |
| 23 Feb 2026 | JP Morgan | Maintains | Underweight | $5.00 → $7.00 |
| 23 Feb 2026 | JP Morgan | Maintains | Underweight | — |
| 18 Sept 2025 | JP Morgan | Assumes | Underweight | $5.00 |
| 17 Dec 2024 | JP Morgan | Downgrade | Underweight | — |
| 11 Oct 2024 | Keybanc | Initiates | Sector Weight | — |
| 13 Mar 2024 | JP Morgan | Maintains | Neutral | — |
| 8 Feb 2024 | Goldman Sachs | Maintains | Neutral | — |
| 15 Feb 2023 | Goldman Sachs | Maintains | Neutral | — |
| 8 Feb 2023 | JP Morgan | Maintains | Neutral | — |
| 23 Nov 2022 | Goldman Sachs | Maintains | Neutral | — |
| 16 Nov 2022 | Citigroup | Maintains | Neutral | — |
| 15 Sept 2022 | Barclays | Maintains | Equal-Weight | — |
| 16 May 2022 | Baird | Downgrade | Neutral | — |
| 11 May 2022 | Piper Sandler | Maintains | Underweight | — |
| 20 Apr 2022 | Piper Sandler | Downgrade | Underweight | — |
| 28 Dec 2021 | Goldman Sachs | Downgrade | Neutral | — |
| 27 Dec 2021 | Barclays | Downgrade | Equal-Weight | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
INNV appears in the Radar on the weeks it earns a place.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and serversIn full
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 4 Nov 2026, InnovAge Holding Corp. returned +102.1% against +14.8% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 4% of US stocks
Cheaper than 63% of US stocks
Cheaper than 18% of US stocks
Cheaper than 5% of US stocks
Higher than 67% of US stocks
Higher than 58% of US stocks
Higher than 26% of US stocks
Higher than 55% of US stocks
Higher than 29% of US stocks
Higher than 44% of US stocks
Higher than 47% of US stocks
Higher than 1% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
InnovAge Holding Corp. has a market value of $1.3B and an enterprise value of $1.2B.
Revenue in the twelve months to 30 June 2026: $989.7M. The latest quarter grew 18.3% year on year.
Net income over the same four quarters: −$683K, a −0.1% net margin.
Diluted earnings per share, trailing twelve months: $−0.02.
Free cash flow in the twelve months to 30 June 2026: $50.4M.
InnovAge Holding Corp. spent $0.0 on share buybacks in the twelve months to 30 June 2026.
Trailing P/E: 162.4×; forward P/E: 18.4× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 0.00%, paying out 0% of earnings.
InnovAge Holding Corp. employs 2,500 people — $396K of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own InnovAge Holding Corp. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
InnovAge Holding Corp. held its Q1 2027 earnings call on November 3, 2026. The excerpt lists company executives and analysts participating but provides no discussion of results or business updates.
Why it matters — INNV watchers can note the call and its participants, though the provided excerpt contains no substantive earnings details.
InnovAge Holding Corp. reported quarterly earnings of $0.14 per share, above the Zacks Consensus Estimate of $0.11. Earnings were $0.06 per share in the year-ago quarter.
Why it matters — INNV watchers may note that quarterly earnings exceeded the consensus estimate and the year-ago result.
InnovAge reported fiscal first-quarter 2027 revenue of $264.8 million, up 12.1% year over year, with participant growth and higher capitation rates contributing. Net income increased to $20.9 million from $7.7 million, and adjusted EBITDA rose to $31.3 million from $17.6 million.
Why it matters — The results give INNV watchers an update on quarterly revenue growth and profitability.
InnovAge announced financial results for the fiscal first quarter ended September 30, 2026. CEO Patrick Blair attributed strong financial performance to continued census growth and disciplined clinical and operational execution.
Why it matters — The update provides INNV watchers with the company’s quarterly results and management’s stated drivers of performance.
InnovAge said it will report fiscal first-quarter 2027 financial results after market close on November 3, 2026. The company will host a conference call to review the results at 5 p.m.
Why it matters — INNV watchers can note the scheduled date and time for the company’s financial results and related conference call.
The 3 Wall Street analysts covering InnovAge Holding Corp. have a median 12-month price target of $12, with estimates ranging from $10 to $14. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 3 analysts covering InnovAge Holding Corp., 1 rate it a Buy, 1 a Hold and 1 a Sell. Ticker Nerd's systematic factor model ranks InnovAge Holding Corp. 99 out of 100 across roughly 4,600 US stocks as at 4 Nov 2026. None of this is personal advice — it does not consider your circumstances.
As at 4 Nov 2026, InnovAge Holding Corp. ranks 99 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Quality (91 of 100).
No one can know that. What the data says: the median 12-month target from 3 analysts implies +22.7% from the last close, and Ticker Nerd's factor model ranks InnovAge Holding Corp. 99 out of 100 as at 4 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering InnovAge Holding Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for INNV are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $10 to $14 over the next 12 months.
InnovAge Holding Corp. returned +102.1% over the 12 months to 4 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.
InnovAge Holding Corp. is a healthcare services company focused on managing the care of frail, high-cost seniors, particularly those who are eligible for both Medicare and Medicaid.
The most recent item we track (Seeking Alpha, 4 Nov 2026): "InnovAge Holding Corp. (INNV) Q1 2027 Earnings Call Transcript". InnovAge Holding Corp. held its Q1 2027 earnings call on November 3, 2026. The excerpt lists company executives and analysts participating but provides no discussion of results or business updates.
InnovAge Holding Corp. is a healthcare services company focused on managing the care of frail, high-cost seniors, particularly those who are eligible for both Medicare and Medicaid. Through its Program of All-inclusive Care for the Elderly (PACE) model, the company provides coordinated medical and support services designed to help older adults remain in their homes and communities for as long as possible. Its offerings include primary and specialty care delivered at centers, in-home assistance, therapy services, dental and mental health care, meals, transportation, and ongoing care management. InnovAge Holding Corp. serves a participant-centered role in senior healthcare by integrating clinical, social, and day-to-day support services under one care framework. Headquartered in Denver, Colorado, the company operates as a significant provider in the U.S. senior care market.
CEO Mr. Patrick Blair · 2,500 employees · United States · https://www.innovage.com
